Antimicrobial Therapy for ICU-Acquired Infection: Time for a Reappraisal. In: Vincent J, editor. Yearbook of Intensive Care and Emergency Medicine 1998. Berlin: Springer Berlin Heidelberg; 1998. pp. 283-91. [DOI: 10.1007/978-3-642-72038-3_25]

Rapid and specific molecular identification of methicillin-resistant Staphylococcus aureus in endotracheal aspirates from mechanically ventilated patients

Multiplex amplification of femA and mecA genetic determinants allowed an early and rapid identification of methicillin-resistant Staphylococcus aureus (MRSA) in endotracheal aspirates of mechanically ventilated patients. femA and/or mecA amplification and bacteriological results were concordant in 57 of 60 samples. In all three discrepant cases, complementary bacteriological tests confirmed the presence of MRSA first identified by molecular analysis. These results underline the value and rapidity of this molecular diagnosis for MRSA infection and control surveillance in intensive care units. Rapid MRSA detection is expected to have a significant clinical impact not only on patient outcome but also on the costs for isolation and treatment.